Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. Articles
  3. surgical resection
Show results for
Products
Services
Applications

Companies

News
Articles
Videos

Refine by
Date

  • Older

Surgical Resection Articles & Analysis

8 articles found

Generating a robust prediction model for stage I lung adenocarcinoma recurrence after surgical resection

Generating a robust prediction model for stage I lung adenocarcinoma recurrence after surgical resection

Abstract Lung cancer mortality remains high even after successful resection. Adjuvant treatment benefits stage II and III patients, but not stage I patients, and most studies fail to predict recurrence in stage I patients. Our study included 211 lung adenocarcinoma patients (stages I–IIIA; 81% stage I) who received curative resections at Taipei Veterans General Hospital between January ...

ByAuspex Diagnostics


Comparison of genomic signatures of non-small cell lung cancer recurrence between two microarray platforms

Comparison of genomic signatures of non-small cell lung cancer recurrence between two microarray platforms

Materials and Methods We analyzed gene expression in frozen lung cancer tissue from 59 selected patients who had undergone surgical resection of NSCLC. These patients were divided into two groups: group R, patients who had a tumor recurrence within four years, n=37; group NR, patients who remained disease-free four years following initial surgery, n=22. ...

ByAuspex Diagnostics


A new model using artificial intelligence to predict recurrence after surgical resection of stage I-II non-small cell lung cancer.

A new model using artificial intelligence to predict recurrence after surgical resection of stage I-II non-small cell lung cancer.

Abstract Background: Five-year survival for stage I-II lung cancer is quite low even after complete surgical resection. Current guidelines recommend adjuvant treatment only for selected patients with stage II or higher disease. ...

ByAuspex Diagnostics


Discovery of Bispecific Antibodies and Immune Checkpoint Inhibitors That Kill Glioblastoma Cells and Melanoma Cells, and Block the Metastasis of Malignant Melanoma Cells to the Lung by Over 90%

Discovery of Bispecific Antibodies and Immune Checkpoint Inhibitors That Kill Glioblastoma Cells and Melanoma Cells, and Block the Metastasis of Malignant Melanoma Cells to the Lung by Over 90%

In greater than 50% of affected patients the tumors are diagnosed at advanced stages with metastatic spread that precludes curative surgical resection. Background Recent studies of NSCLC have highlighted genetic abnormalities that underlie these tumors. ...

ByOcean Biomedical


Multifunctional Black Bioactive Ceramic Material Developed Recently

Multifunctional Black Bioactive Ceramic Material Developed Recently

However, there are many special tissue damages in clinical practice, such as tissue defects after surgical resection of bone tumors or skin cancer tissues. It is necessary to remove the remaining tumor cells before repairing the tissue defects to avoid tumor recurrence. ...

ByMatexcel


The New Guidelines For Interventional Oncology - And How Micromateâ„¢ Seamlessly Fits Into Them

The New Guidelines For Interventional Oncology - And How Micromateâ„¢ Seamlessly Fits Into Them

With the paradigm shift towards minimally invasive approaches, IO is taking a more prominent role in the oncology realm, as it is less invasive than traditional methods and approaches, and interventional radiologists often find creative and innovative ways to treat lesions while minimizing the impact of the intervention. While the surgical resection of tumors ...

ByInterventional Systems (iSYS)


Intracranial Neoplasms: The Evolution of Radiotherapies

Intracranial Neoplasms: The Evolution of Radiotherapies

KEY TAKEAWAYS The standard of care for aggressive brain tumors is resection.1 Adjuvant therapy (chemotherapy or radiation) is recommended when surgery is unable to remove all traces of a tumor.1,3 The most common method of adjuvant radiation treatment is fractionated EBRT.1,3 Radiation travels from outside of the body through the skull and into the brain, exposing healthy ...

ByGT Medical Technologies, Inc.


GammaTile Surgically Targeted Radiation Therapy (STaRT) Improving Access to Brain Tumor Care without Compromising Outcomes

GammaTile Surgically Targeted Radiation Therapy (STaRT) Improving Access to Brain Tumor Care without Compromising Outcomes

CURRENT STANDARD OF CARE The current initial standard of care for aggressive brain tumors—either primary brain tumors (ie, tumors that originate inside the brain) or metastatic tumors (ie, tumors from cancers that originate outside of the brain)—is maximum safe surgical resection. After surgery, a follow-up treatment, also referred to as adjuvant ...

ByGT Medical Technologies, Inc.

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT